Year |
Citation |
Score |
2011 |
Bhonagiri P, Pattar GR, Habegger KM, McCarthy AM, Tackett L, Elmendorf JS. Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance. Endocrinology. 152: 3373-84. PMID 21712361 DOI: 10.1210/En.2011-1295 |
0.792 |
|
2010 |
Bhonagiri P, Pattar GR, Horvath EM, Habegger KM, McCarthy AM, Elmendorf JS. Hexosamine biosynthesis pathway flux contributes to insulin resistance via altering membrane phosphatidylinositol 4,5-bisphosphate and cortical filamentous actin (Endocrinology (2009) 150, (1636-1645) DOI: 10.1210/en.2008-1102) Endocrinology. 151: 2967. DOI: 10.1210/En.2010-0489 |
0.766 |
|
2009 |
Bhonagiri P, Pattar GR, Horvath EM, Habegger KM, McCarthy AM, Elmendorf JS. Hexosamine biosynthesis pathway flux contributes to insulin resistance via altering membrane phosphatidylinositol 4,5-bisphosphate and cortical filamentous actin. Endocrinology. 150: 1636-45. PMID 19036880 DOI: 10.1210/En.2008-1102 |
0.793 |
|
2006 |
Pattar GR, Tackett L, Liu P, Elmendorf JS. Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutation Research. 610: 93-100. PMID 16870493 DOI: 10.1016/J.Mrgentox.2006.06.018 |
0.742 |
|
2006 |
Chen G, Liu P, Pattar GR, Tackett L, Bhonagiri P, Strawbridge AB, Elmendorf JS. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Molecular Endocrinology (Baltimore, Md.). 20: 857-70. PMID 16339278 DOI: 10.1210/Me.2005-0255 |
0.707 |
|
2004 |
Chen G, Raman P, Bhonagiri P, Strawbridge AB, Pattar GR, Elmendorf JS. Protective effect of phosphatidylinositol 4,5-bisphosphate against cortical filamentous actin loss and insulin resistance induced by sustained exposure of 3T3-L1 adipocytes to insulin. The Journal of Biological Chemistry. 279: 39705-9. PMID 15277534 DOI: 10.1074/Jbc.C400171200 |
0.727 |
|
Low-probability matches (unlikely to be authored by this person) |
2020 |
Jerkins GW, Pattar GR, Kannarr SR. A Review of Topical Cyclosporine A Formulations-A Disease-Modifying Agent for Keratoconjunctivitis Sicca. Clinical Ophthalmology (Auckland, N.Z.). 14: 481-489. PMID 32109984 DOI: 10.2147/Opth.S228070 |
0.213 |
|
2019 |
Pattar GR, Jerkins G, Evans DG, Torkildsen GL, Ousle GW, Hollander DA, Holdbrook M, Senchyna M. Symptom improvement in dry eye subjects following intranasal tear neurostimulation: Results of two studies utilizing a controlled adverse environment. The Ocular Surface. PMID 31542368 DOI: 10.1016/J.Jtos.2019.09.006 |
0.183 |
|
2014 |
Arthur SN, Cantor LB, WuDunn D, Pattar GR, Catoira-Boyle Y, Morgan LS, Hoop JS. Efficacy, safety, and survival rates of IOP-lowering effect of phacoemulsification alone or combined with canaloplasty in glaucoma patients. Journal of Glaucoma. 23: 316-20. PMID 23377581 DOI: 10.1097/Ijg.0B013E3182741Ca9 |
0.182 |
|
2022 |
Torkildsen GL, Pattar GR, Jerkins G, Striffler K, Nau J. Efficacy and Safety of Single-Dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial. Clinical Therapeutics. PMID 35965109 DOI: 10.1016/j.clinthera.2022.07.006 |
0.027 |
|
Hide low-probability matches. |